Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
基本信息
- 批准号:8402619
- 负责人:
- 金额:$ 36.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-01-03 至 2014-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbdomenAddressAffectAngiopoietinsAortaBasement membraneBindingBiological AssayBlocking AntibodiesBlood CellsBlood VesselsBrainCD80 geneCXCR4 geneCardiovascular DiseasesCell LineCell ProliferationCell SurvivalCollagenComplexCytokine ReceptorsDataDefectDevelopmentDevelopmental ProcessDiabetes MellitusDorsalEmbryoEndothelial CellsEventExtracellular MatrixFibrinGrowthGrowth FactorHematopoiesisHematopoieticHematopoietic stem cellsHemorrhageHumanIn VitroIntegrinsInterleukin-3LaboratoriesLigandsLinkMalignant NeoplasmsMediator of activation proteinMesenchymeModelingMolecularMorphogenesisPericytesPhenotypePhorbol EstersPhosphotransferasesPlatelet-Derived Growth FactorProcessProtein IsoformsProto-Oncogene Protein c-kitQuailSerumSerum-Free Culture MediaSignal TransductionStem Cell FactorStromal Cell-Derived Factor 1Supporting CellSystemTransforming Growth Factor betaTubeVascular Endothelial Growth FactorsVascularizationWorkbasebone morphogenic proteincell behaviorcofactorcytokinefascinatehuman diseasein vivoinhibitor/antagonistinterestmonolayernovelprecursor cellreceptorresponsescreeningstemsynergismvasculogenesis
项目摘要
In this new proposal, we investigate our novel finding that a unique combination of hematopoietic stem
cell cytokines (i.e. stem cell factor-SCF; interleukin 3- IL-3; and stromal-derived factor-1 alpha- SDF-1¿)
control human endothelial cell (EC) tube morphogenesis and EC-pericyte tube coassembly under
defined serum-free conditions (and in the absence of phorbol ester) in 3D collagen matrices.
Interestingly, VEGF has no influence by itself and requires the synergistic action of these hematopoietic factors
in order to exert an effect on EC sprouting, its major morphogenic influence. We propose the hypothesis that
SCF, IL-3 and SDF-1¿ are critical regulators of vascular morphogenesis which act in a synergistic manner and
are necessary cofactors for the action of known mediators of developmental vascularization (e.g. VEGF and
BMP-4). Combined administration of c-Kit (the SCF receptor) and CXCR4 (the SDF-1¿ receptor) inhibitors or
blocking antibodies to SCF and IL-3 leads to vascular hemorrhage phenotypes in developing quail embryos
that relates to defects in vessel formation and remodeling. Also, we show that the three factors synergize to
activate Src, B-Raf and Erk kinases and induce the expression of the ¿2¿1 integrin and Pak2 which are known
regulators of vascular morphogenesis. We will elucidate the molecular basis for the signaling synergism of the
three cytokines in ECs, how these factors interface with VEGF, BMP-4, and pericytes to control EC sprouting
and how they affect both ECs and pericytes during tube coassembly and maturation events in vitro and in vivo.
We propose three specific aims which are;
Specific Aim #1. To elucidate the signaling mechanisms by which SCF, IL-3 and SDF-1¿ synergize to
stimulate vasculogenic EC tube assembly in 3D extracellular matrices.
Specific Aim #2. To determine how SCF, IL-3 and SDF-1¿ affect VEGF and BMP-4 signaling to control
EC sprouting responses in 3D extracellular matrices.
Specific Aim #3. To determine how SCF, IL-3 and SDF-1¿ act to regulate pericyte-induced EC
sprouting responses and vasculogenic EC-pericyte tube coassembly in 3D extracellular matrices.
在这个新提案中,我们研究了我们的新发现,即造血干细胞的独特组合
细胞因子(即干细胞因子-SCF;白细胞介素 3-IL-3;和基质衍生因子-1 α-SDF-1¿)
控制人内皮细胞 (EC) 管形态发生和 EC-周细胞管共组装
定义了 3D 胶原基质中的无血清条件(且不存在佛波酯)。
有趣的是,VEGF本身没有影响,需要这些造血因子的协同作用
以对EC发芽产生影响,这是其主要的形态发生影响。我们提出假设
SCF、IL-3 和 SDF-1¿ 是血管形态发生的关键调节因子,它们以协同方式发挥作用,
是已知的发育血管化介质(例如 VEGF 和
BMP-4)。联合使用 c-Kit(SCF 受体)和 CXCR4(SDF-1¿ 受体)抑制剂或
SCF 和 IL-3 阻断抗体会导致鹌鹑胚胎发育中的血管出血表型
这与血管形成和重塑的缺陷有关。此外,我们还表明这三个因素可以协同作用
激活 Src、B-Raf 和 Erk 激酶并诱导已知的 ¿2¿1 整合素和 Pak2 的表达
血管形态发生的调节因子。我们将阐明信号协同作用的分子基础
EC 中的三种细胞因子,这些因子如何与 VEGF、BMP-4 和周细胞相互作用来控制 EC 萌芽
以及它们在体外和体内管共组装和成熟过程中如何影响内皮细胞和周细胞。
我们提出三个具体目标:
具体目标#1。阐明 SCF、IL-3 和 SDF-1¿ 协同作用的信号传导机制
刺激 3D 细胞外基质中的血管生成 EC 管组装。
具体目标#2。确定 SCF、IL-3 和 SDF-1 如何影响 VEGF 和 BMP-4 信号传导以控制
3D 细胞外基质中的 EC 出芽反应。
具体目标#3。确定 SCF、IL-3 和 SDF-1 如何调节周细胞诱导的 EC
3D 细胞外基质中的发芽反应和血管生成 EC-周细胞管共组装。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George E Davis其他文献
Talin1 is required for cardiac Z-disk stabilization and endothelial integrity in zebrafish.
Talin1 是斑马鱼心脏 Z 盘稳定和内皮完整性所必需的。
- DOI:
10.1096/fj.15-273409 - 发表时间:
2015 - 期刊:
- 影响因子:0
- 作者:
Qing Wu;Jiaojiao Zhang;Wonshill Koh;Qingming Yu;Xiaojun Zhu;Adam Amsterdam;George E Davis;M Amin Arnaout;Jing-Wei Xiong - 通讯作者:
Jing-Wei Xiong
George E Davis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George E Davis', 18)}}的其他基金
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
- 批准号:
10192817 - 财政年份:2020
- 资助金额:
$ 36.06万 - 项目类别:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
- 批准号:
10619624 - 财政年份:2020
- 资助金额:
$ 36.06万 - 项目类别:
Molecular basis for defective pericyte-endothelial cell interactions regulating vascular malformations
调节血管畸形的有缺陷的周细胞-内皮细胞相互作用的分子基础
- 批准号:
10408085 - 财政年份:2020
- 资助金额:
$ 36.06万 - 项目类别:
Novel growth factor and signaling requirements for human capillary tube assembly
人体毛细管组装的新型生长因子和信号传导要求
- 批准号:
9102169 - 财政年份:2015
- 资助金额:
$ 36.06万 - 项目类别:
Novel growth factor and signaling requirements for human capillary tube assembly
人体毛细管组装的新型生长因子和信号传导要求
- 批准号:
8942261 - 财政年份:2015
- 资助金额:
$ 36.06万 - 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
- 批准号:
8021934 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
- 批准号:
8207865 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Hematopoietic stem cell cytokine control of developmental vascularization
造血干细胞细胞因子控制发育血管化
- 批准号:
8593308 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Molecular Control of EC Lumen Formation by MT1-MMP
MT1-MMP 对 EC 腔形成的分子控制
- 批准号:
7373336 - 财政年份:2008
- 资助金额:
$ 36.06万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.06万 - 项目类别:
Research Grant














{{item.name}}会员




